Full Press Release Details
C TECHNOLOGIES, INC.
FINANCIAL STATEMENTS
YEARS ENDED DECEMBER 31, 2018 AND 2017
C TECHNOLOGIES, INC.
| Page | ||||
| Independent Auditors Report | 1 | |||
| Financial Statements | ||||
| Balance Sheets | 2 | |||
| Statements of Income | 3 | |||
| Statements of Stockholder s Equity | 4 | |||
| Statements of Cash Flows | 5 | |||
| Notes to Financial Statements | 6 |
INDEPENDENT AUDITOR S REPORT
of C Technologies, Inc.
We have audited the accompanying financial statements of C Technologies, Inc., which comprise the balance sheets as of December 31, 2018 and 2017, and
the related statements of income, stockholder s equity, and cash flows for the years then ended, and the related notes to the financial statements.
Management s Responsibility for the Financial Statements
Management is responsible for the preparation and fair presentation of these financial statements in accordance with accounting principles generally accepted
in the United States of America; this includes the design, implementation, and maintenance of internal control relevant to the preparation and fair presentation of financial statements that are free from material misstatement, whether due to fraud
Auditor s Responsibility
responsibility is to express an opinion on these financial statements based on our audits. We conducted our audits in accordance with auditing standards generally accepted in the United States of America. Those standards require that we plan and
perform the audit to obtain reasonable assurance about whether the financial statements are free from material misstatement.
An audit involves performing
procedures to obtain audit evidence about the amounts and disclosures in the financial statements. The procedures selected depend on the auditor s judgment, including the assessment of the risks of material misstatement of the financial
statements, whether due to fraud or error. In making those risk assessments, the auditor considers internal control relevant to the Company s preparation and fair presentation of the financial statements in order to design audit procedures that
are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company s internal control. Accordingly, we express no such opinion. An audit also includes evaluating the appropriateness of
accounting policies used and the reasonableness of significant accounting estimates made by management, as well as evaluating the overall presentation of the financial statements.
We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinion.
In our opinion, the financial statements
referred to above present fairly, in all material respects, the financial position of C Technologies, Inc. as of December 31, 2018 and 2017, and the results of its operations and its cash flows for the years then ended in accordance with
accounting principles generally accepted in the United States of America.
C Technologies, Inc.
| December 31, | ||||||||
| 2018 | 2017 | |||||||
| Assets | ||||||||
| Current assets: | ||||||||
| Cash and cash equivalents | $ | 7,693,000 | $ | 7,732,000 | ||||
| Accounts receivable | 3,302,000 | 4,132,000 | ||||||
| Inventories, net | 1,740,000 | 1,522,000 | ||||||
| Prepaid expenses and other current assets | 31,000 | 17,000 | ||||||
| Total current assets | 12,766,000 | 13,403,000 | ||||||
| Property and equipment, net | 44,000 | 28,000 | ||||||
| Other assets | 17,000 | 17,000 | ||||||
| Total assets | $ | 12,827,000 | $ | 13,448,000 | ||||
| Liabilities and stockholders equity | ||||||||
| Current liabilities: | ||||||||
| Accounts payable | $ | 345,000 | $ | 348,000 | ||||
| Accrued expenses | 907,000 | 610,000 | ||||||
| Deferred revenue, current | 1,255,000 | 972,000 | ||||||
| Total current liabilities | 2,507,000 | 1,930,000 | ||||||
| Deferred revenue, non-current | 92,000 | 145,000 | ||||||
| Total liabilities | 2,599,000 | 2,075,000 | ||||||
| Commitments and contingencies | ||||||||
| Stockholders equity: | ||||||||
| Common stock, $1.00 par value, 400 authorized, 400 shares at December 31, 2018 and 2017 issued and outstanding | ||||||||
| Retained earnings | 10,228,000 | 11,373,000 | ||||||
| Total stockholders equity | 10,228,000 | 11,373,000 | ||||||
| Total liabilities and stockholders equity | $ | 12,827,000 | $ | 13,448,000 |
The accompanying notes are an integral part of these financial statements.
C Technologies, Inc.
Statements of Income
| Years Ended December 31, | ||||||||
| 2018 | 2017 | |||||||
| Revenue, net | $ | 23,707,000 | $ | 19,392,000 | ||||
| Operating expenses: | ||||||||
| Cost of revenue | 8,172,000 | 6,960,000 | ||||||
| Research and development | 649,000 | 360,000 | ||||||
| Selling, general and administrative | 4,299,000 | 6,045,000 | ||||||
| Total operating expenses | 13,120,000 | 13,365,000 | ||||||
| Income from operations | 10,587,000 | 6,027,000 | ||||||
| Other income | 75,000 | 18,000 | ||||||
| Net income | $ | 10,662,000 | $ | 6,045,000 |
The accompanying notes are an integral part of these financial statements.
C Technologies, Inc.
Statements of Stockholder s Equity
| Number of Shares | Common Stock | Retained Earnings | Total Stockholder s Equity | |||||||||||||
| December 31, 2016 | 400 | $ | $ | 9,232,000 | $ | 9,232,000 | ||||||||||
| Net income | 6,045,000 | 6,045,000 | ||||||||||||||
| Distributions | (3,904,000 | ) | (3,904,000 | ) | ||||||||||||
| December 31, 2017 | 400 | 11,373,000 | 11,373,000 | |||||||||||||
| Net income | 10,662,000 | 10,662,000 | ||||||||||||||
| Distributions | (11,807,000 | ) | (11,807,000 | ) | ||||||||||||
| December 31, 2018 | 400 | $ | $ | 10,228,000 | $ | 10,228,000 |
The accompanying notes are an integral part of these financial statements.
C Technologies, Inc.
Statements of Cash Flows
| Years Ended December 31, | ||||||||
| 2018 | 2017 | |||||||
| Cash flows from operating activities: | ||||||||
| Net income | $ | 10,662,000 | $ | 6,045,000 | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||
| Depreciation | 18,000 | 24,000 | ||||||
| Changes in assets and liabilities: | ||||||||
| Accounts receivable | 830,000 | (1,248,000 | ) | |||||
| Inventories | (218,000 | ) | (29,000 | ) | ||||
| Prepaid expenses and other assets | (14,000 | ) | (17,000 | ) | ||||
| Accounts payable | (3,000 | ) | (78,000 | ) | ||||
| Accrued expenses | 297,000 | 121,000 | ||||||
| Deferred revenue | 230,000 | 384,000 | ||||||
| Net cash provided by operating activities | 11,802,000 | 5,202,000 | ||||||
| Cash flows from investing activities: | ||||||||
| Purchases of property, plant and equipment | (34,000 | ) | ||||||
| Net cash used in investing activities | (34,000 | ) | ||||||
| Cash flows from financing activities: | ||||||||
| Distributions to stockholder | (11,807,000 | ) | (3,904,000 | ) | ||||
| Net cash used in financing activities | (11,807,000 | ) | (3,904,000 | ) | ||||
| Net increase (decrease) in cash and cash equivalents | (39,000 | ) | 1,298,000 | |||||
| Cash and cash equivalents, beginning of period | 7,732,000 | 6,434,000 | ||||||
| Cash, cash equivalents and restricted cash, end of period | $ | 7,693,000 | $ | 7,732,000 |
The accompanying notes are an integral part of these financial statements.
C Technologies, Inc.
Notes to the Financial Statements
NOTE 1 NATURE OF BUSINESS
financial statements include the accounts of C Technologies, Inc. (the Company ). The Company designs and manufactures solutions for the biopharmaceutical industry. Specifically, it has developed a unique way to perform UV/Vis analysis
using Slope Spectroscopy. By leveraging the advantages of this technique, the Company has been able to create a platform by which its customers can now make off line concentration measurements of their drug substance, at various points in the
manufacturing process. This testing can be performed now by manufacturing personnel, quality control and formulation laboratories within biopharma. After becoming an accepted standard in the industry, the Company launched an in-line version of the instrument called FlowVPE which over the next few years will allow manufacturing and production facilities to measure protein concentration in line eliminating the need to send samples to
quality control labs for testing.
NOTE 2 SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
The financial statements
included herein have been prepared by the Company in accordance with generally accepted accounting principles in the United States ( U.S. GAAP ) and should be read in conjunction with the audited financial statements and accompanying notes
preparation of the financial statements require management to make estimates and assumptions that affect the reported amounts of assets, liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the
reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.
The Company s operations are
affected by numerous factors including market acceptance, changes in technologies and new laws and government regulations and policies. The Company cannot predict what impact, if any, the occurrence of these or other events might have on the
Company s operations.
Significant estimates and assumptions made by management are used for, but not limited to, the allowance for doubtful accounts
and sales returns, the reserve for slow moving or obsolete inventories and the fair value of long-lived assets. Actual results could differ from these estimates.
Cash and Cash Equivalents
The Company classifies
all highly liquid investments with original maturities of 90 days or less at the time of purchase as cash and cash equivalents.
Credit Risks for Cash
The Company s cash balances in banks are insured by the Federal Deposit Insurance Corporation subject to certain
performs ongoing credit evaluations of its customers and generally does not require collateral. Accounts receivable are carried at original invoice amount less any estimate made for doubtful receivables based on a review of all outstanding amounts
monthly. No interest is charged on past due accounts. Historically, the Company has not maintained an allowance for doubtful accounts and has incurred zero bad debt expense for the years ended December 31, 2018 and 2017.
C Technologies, Inc.
Notes to the Financial Statements
NOTE 2 SIGNIFICANT ACCOUNTING POLICIES (Continued)
Inventories are stated at the lower of cost or net realizable value accounted for using the first-in, first-out method. The Company writes down inventory that has become obsolete, inventory that has a cost basis in excess of its expected net realizable value, and inventory in excess of expected requirements to cost
of product revenue. Manufacturing of finished goods is done to order and tested for quality specifications prior to shipment.
Work-in-process and finished products inventories consist of material, labor, outside processing costs and manufacturing overhead.
Property and equipment are
recorded at cost, net of accumulated depreciation and amortization. Depreciation of property and equipment is provided using the straight-line method over the estimated useful lives (ranging from 3 to 20 years). Leasehold improvements are amortized
on a straight-line basis over the lesser of the lease term or the estimated useful life of the asset. Amortization of leasehold improvements is included with depreciation expense.
The Company periodically reviews its long-lived assets to determine potential impairment by comparing the carrying value of the long-lived assets with the
estimated future net undiscounted cash flows expected to result from the use of the assets, including cash flows from disposition. Long-lived assets evaluated for impairment are grouped with other assets to the lowest level for which identifiable
cash flows are largely independent of the cash flows of other groups of assets and liabilities. Should the sum of the expected future net cash flows be less than the carrying value, the Company would recognize an impairment loss at that date. An
impairment loss would be measured by comparing the amount by which the carrying value exceeds the fair value (estimated discounted future cash flows) of the long-lived assets. No impairments related to long-lived assets were recorded during the
years ended December 31, 2018 and 2017.
No provision has been made for federal and state income taxes for the years ended December 31, 2018 and 2017. The Company has elected to be an
S Corporation whereby the stockholder accounts for his share of the Company s earnings, losses, deductions and credits on his federal and state income tax returns.
Several states impose a sales tax on
product sales to non-exempt customers. The taxes are recorded as liabilities until remitted to state agencies. The Company s accounting policy is to exclude the tax collected and remitted to the
appropriate state from revenue and direct costs.
Defined Contribution Profit Sharing 401(k) Plan
The Company has a defined contribution profit sharing 401(k) plan covering all eligible employees. The Company may make discretionary contributions to the
plan. Company contributions were approximately $88,000 and $62,000 for the years ended December 31, 2018 and 2017, respectively.
C Technologies, Inc.
Notes to the Financial Statements
NOTE 2 SIGNIFICANT ACCOUNTING POLICIES (Continued)
The Company s revenue
recognition policy is to recognize revenues from product sales and services when persuasive evidence of an arrangement exists, product delivery, including customer acceptance, has occurred or services have been rendered, the price is fixed or
determinable and collectability is reasonably assured. Determination of whether these criteria have been met are based on management s judgments primarily regarding the fixed nature of the fee charged for the product delivered and the
collectability of those fees. The Company has had no significant write-offs of uncollectible invoices in the periods presented.
element such as equipment, consumables, and services are contained in a single arrangement, the Company allocates revenue between the elements based on each element s relative selling price, provided that each element meets the criteria for
treatment as a separate unit of accounting. An item is considered a separate unit of accounting if it has value to the customer on a stand-alone basis. The selling price of the undelivered elements is determined by the price charged when the element
is sold separately, or in cases when the item is not sold separately, by third-party evidence of selling price or management s best estimate of selling price.
The Company s product revenues are from the sale of measurement systems, consumables, service contracts, accessories and other products. On product sales
to end customers, revenue is recognized, net of discounts, when both the title and risk of loss have transferred to the customer, as determined by the shipping terms provided there are no uncertainties regarding acceptance, and all obligations have
been completed. Generally, product arrangements for equipment sales are multiple element arrangements, and may include services, such as installation and training, and multiple products, such as consumables and spare parts. Based on terms and
conditions of the product arrangements, the Company believes that these services and undelivered products can be accounted for separately from the delivered product element as the delivered products have value to our customers on a standalone basis.